Skip to main
PACS

PACS Stock Forecast & Price Target

PACS Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PACS Group is well-positioned to thrive in the post-acute healthcare market with its strong focus on skilled nursing care and diversified portfolio of services for seniors. The company's impressive financial performance, highlighted by a 2027E adjusted EBITDA of $649.0M and a leading scale in the market, makes it a compelling investment opportunity with strong secular industry tailwinds. Its decentralized operating model, robust technology assets, and strong financial flexibility provide a competitive edge in adapting to local dynamics and driving attractive benefits in payor contracting and referral source relationships. However, potential regulatory risks, government reimbursement concerns, and integration challenges for acquisitions could pose risks to its growth trajectory.

Bears say

PACS Group is well-positioned in the post-acute healthcare market with a strong presence in key markets and attractive clinical capabilities; however, its current leverage position of 0.3X adj. EBITDA may limit its ability to complete significant M&A deals in the near future. Furthermore, while the company's M&A pipeline appears strong, the potential for overpaying for deals in competitive markets may pose a risk to its overall financial health.

PACS has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PACS Group, Inc. (PACS) Forecast

Analysts have given PACS a Buy based on their latest research and market trends.

According to 5 analysts, PACS has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PACS Group, Inc. (PACS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.